Prostate Cancer Drug Development Summit
Evvnt Promotion / evvnt
Archiv
17.08.2021 - 19.08.2021 Online
Time: 09:00 - 17:00
Kongressthemen
The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma, biotech and pioneering academics to unite under a common and ambitious goal of accelerating the practical discovery, translation, and clinical development of safe and effective treatments for prostate cancer.
The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma, biotech and pioneering academics to unite under a common and ambitious goal of accelerating the practical discovery, translation, and clinical development of safe and effective treatments for prostate cancer.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Speakers: Ellen Filvaroff, Bristol-Myers Squibb, Vivek Arora, Bristol Myers Squibb, Alison Crawford, Regeneron Pharmaceuticals, Inc, Maggie Janat-Amsbury, Amgen, Andrew Cavey, Novartis/Advanced Accelerator Applications and more.
Speakers: Ellen Filvaroff, Bristol-Myers Squibb, Vivek Arora, Bristol Myers Squibb, Alison Crawford, Regeneron Pharmaceuticals, Inc, Maggie Janat-Amsbury, Amgen, Andrew Cavey, Novartis/Advanced Accelerator Applications and more.
Anfragen und Anmeldung:
https://go.evvnt.com/757702-2?pid=4832
Frau Jessica Durston
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
USD 1799.0 - USD 3297.0
USD 1799.0 - USD 3297.0
Teilnehmer erwartet
1000
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
